Skip to content

Clinical Evaluation of Two Silicone Hydrogel Contact Lenses

Clinical Evaluation of Two Silicone Hydrogel Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05313412
Enrollment
38
Registered
2022-04-06
Start date
2022-01-27
Completion date
2022-04-21
Last updated
2023-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

This study is to compare the short-term clinical performance and subjective acceptance of two silicone hydrogel soft contact lenses.

Detailed description

This is a double-masked, randomized, bilateral crossover study to compare the short-term clinical performance of two silicone hydrogel soft contact lenses. Each lens type is worn for approximately six hours on separate study days, in random sequence.

Interventions

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. They are aged between 18 and 40 years. 2. They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent. 3. They are willing and able to follow the protocol. 4. They have successfully worn contact lenses within six months of starting the study. 5. They can be satisfactorily fitted with the study contact lenses. 6. They have a contact lens spherical prescription between -0.25 to - 6.00D (inclusive) based on the ocular refraction. 7. They have a spectacle cylindrical correction of -0.75D or less in each eye based on the ocular refraction. 8. They own and habitually wear single vision spectacles. 9. They can attain at least 0.20 logMAR distance high contrast visual acuity in each eye, with the study lenses. 10. They agree not to participate in other clinical research while enrolled on this study.

Exclusion criteria

1. They have an ocular disorder which would normally contraindicate contact lens wear. 2. They have a systemic disorder which would normally contraindicate contact lens wear. 3. They are using any topical medication such as eye drops or ointment. 4. They are aphakic. 5. They have had corneal refractive surgery. 6. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus. 7. They are pregnant or breastfeeding. 8. They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (eg HIV) or a history of anaphylaxis or severe allergic reaction. 9. They have grade 3 or greater of any of the following ocular surface signs: corneal oedema, corneal vascularisation, corneal staining, tarsal conjunctival changes or any other abnormality, which would normally contraindicate contact lens wear. 10. They have taken part in any other clinical trial or research, within two weeks prior to starting this study, which may impact on this particular work.

Design outcomes

Primary

MeasureTime frameDescription
Ease of Lens Insertion6 hoursEase of Lens Insertion is measured on a scale of 0-100 (0-Unmanageable, Lenses impossible to insert; 100-Excellent. No problems with lens insertion)

Countries

United Kingdom

Participant flow

Pre-assignment details

Thirty-eight participants attended the initial visit with all participants completing the study.

Participants by arm

ArmCount
Overall Study
Total study population
38
Total38

Baseline characteristics

CharacteristicOverall Study
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
38 Participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
26 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 380 / 38
other
Total, other adverse events
0 / 380 / 38
serious
Total, serious adverse events
0 / 380 / 38

Outcome results

Primary

Ease of Lens Insertion

Ease of Lens Insertion is measured on a scale of 0-100 (0-Unmanageable, Lenses impossible to insert; 100-Excellent. No problems with lens insertion)

Time frame: 6 hours

ArmMeasureValue (MEAN)Dispersion
Lens AEase of Lens Insertion92.1 units on a scaleStandard Deviation 10.3
Lens BEase of Lens Insertion90.9 units on a scaleStandard Deviation 17.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026